- All sections
- A - Human necessities
- A61M - Devices for introducing media into, or onto, the bodydevices for transducing body media or for taking media from the bodydevices for producing or ending sleep or stupor
- A61M 60/33 - Medical purposes thereof other than the enhancement of the cardiac output for enhancement of in vivo organ perfusion, e.g. retroperfusion of kidneys
Patent holdings for IPC class A61M 60/33
Total number of patents in this class: 27
10-year publication summary
|
0
|
0
|
0
|
3
|
1
|
4
|
3
|
7
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ABIOMED, Inc. | 869 |
5 |
| Magenta Medical Ltd. | 179 |
4 |
| Abiomed Europe GmbH | 287 |
3 |
| Edwards Lifesciences Corporation | 4822 |
3 |
| Cardiacbooster B.V. | 27 |
3 |
| Boston Scientific Scimed, Inc. | 11034 |
1 |
| California Institute of Technology | 4021 |
1 |
| Huntington Medical Research Institutes | 24 |
1 |
| RenalPro Medical, Inc. | 14 |
1 |
| Revamp Medical Ltd. | 14 |
1 |
| inQB8 Medical Technologies, LLC | 48 |
1 |
| Puzzle Medical Devices Inc. | 44 |
1 |
| Relief Cardiovascular, Inc. | 8 |
1 |
| Nidus Biomedical, LLC | 15 |
1 |
| Other owners | 0 |